AG
PFE icon

Ascent Group’s Pfizer PFE Stock Holding History

Ascent Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.78M Sell
157,175
-27,405
-15% -$717K 0.11% 174
2026
Q1 		$5.18M Sell
184,580
-12,534
-6% -$334K 0.18% 116
2025
Q4 		$4.91M Buy
197,114
+32,990
+20% +$832K 0.17% 121
2025
Q3 		$4.18M Buy
164,124
+70,781
+76% +$1.75M 0.15% 137
2025
Q2 		$2.26M Sell
93,343
-9,007
-9% -$210K 0.09% 205
2025
Q1 		$2.59M Buy
102,350
+32,713
+47% +$856K 0.11% 193
2024
Q4 		$1.85M Buy
69,637
+6,925
+11% +$188K 0.14% 180
2024
Q3 		$1.81M Buy
62,712
+11,867
+23% +$346K 0.14% 194
2024
Q2 		$1.42M Buy
50,845
+9,565
+23% +$263K 0.12% 222
2024
Q1 		$1.15M Sell
41,280
-1,260
-3% -$35K 0.1% 262
2023
Q4 		$1.18M Sell
42,540
-8,010
-16% -$242K 0.11% 230
2023
Q3 		$1.5M Sell
50,550
-17,786
-26% -$629K 0.17% 176
2023
Q2 		$2.44M Sell
68,336
-3,305
-5% -$129K 0.27% 101
2023
Q1 		$2.92M Sell
71,641
-26,358
-27% -$1.14M 0.31% 80
2022
Q4 		$5.02M Sell
97,999
-206
-0.2% -$9.88K 0.59% 29
2022
Q3 		$4.57M Buy
98,205
+4,131
+4% +$201K 0.56% 37
2022
Q2 		$4.75M Buy
94,074
+582
+0.6% +$29.7K 0.57% 33
2022
Q1 		$4.84M Sell
93,492
-221
-0.2% -$11.5K 0.56% 33
2021
Q4 		$4.95M Buy
+93,713
New +$4.64M 0.63% 25

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ascent Group's PFE Position: Q2 2026 in Review

Ascent Group reduced its Pfizer (PFE) stake by 15% in Q2 2026, selling an estimated $717K and leaving 157,175 shares worth $3.78M. The position accounts for 0.11% of the portfolio, ranked #174.

Ascent Group first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $5.18M in Q1 2026. 2,826 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Ascent Group held 157,175 shares of Pfizer worth $3.78M as of Q2 2026.
  • Ascent Group sold 27,405 Pfizer shares in Q2 2026, an estimated $717K.
  • Pfizer made up 0.11% of Ascent Group's portfolio in Q2 2026, its #174 holding.
  • Ascent Group first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • Ascent Group's Pfizer position peaked at $5.18M in Q1 2026.
  • 2,826 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Ascent Group's 13F filing for Q2 2026, filed 3 Aug 2026.